Skip to main content
Caplight Logo









LinaTech

LinaTech

Private
SuzhouHealthcare & Life Scienceshttps://www.linatech.com.cn/

Last Round

Series B

Feb 27, 2022

Total Funding Raised

$9.09M

Company Overview

LinaTech is a therapeutic devices company that develops and manufactures medical devices and software for cancer treatment, including linear accelerators and radiotherapy informatics software.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

medical linear acceleratorLINACradiotherapyradiation oncologyMedTechtreatment planning systemTPSimage-guided radiation therapyIGRTmulti-leaf collimatorMLConcology informaticsIMRTVMATSRSSBRTAI auto-contouringAI in radiotherapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LinaTech Comparables

Compare LinaTech with similar companies based on industry and business-model similarity.

LinaTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zhongneng Medical Accelerator System (Guangdong) Co., Ltd.
86%
Akesis, Inc.
84%
MagnetTx Oncology Solutions Ltd
80%

LinaTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 27, 2022
Series AAug 1, 2019
SeedOct 12, 2018
StrategicMay 1, 2014
VC RoundMay 1, 2010

LinaTech Investors

Notable investors and investment history

LinaTech investors
InvestorRounds
健壹资本Seed
Yisheng Investment GroupSeries A
Suzhou Industrial Park Venture Capital Guidance FundSeries A, VC Round
Qiming Venture PartnersSeries A, Strategic
CITIC Industrial InvestmentSeries B
JinYi CapitalSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 2, 2025

    Grew 150% QoQ, from 4 to 10 employees.

  • Feb 27, 2022

    $4.75M round led by CITIC Industrial Investment

LinaTech Filings

Explore SEC and related filing metadata, where available.

LinaTech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about LinaTech's valuation, stock price, and market status.

Is LinaTech a public or private company?

LinaTech is a private company.

What is the current stock price of LinaTech?

LinaTech is a private company with no public stock price. No recent secondary market data is available.

How much is LinaTech worth (valuation)?

Valuation information for LinaTech is not publicly available.

Can I buy LinaTech stock?

LinaTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was LinaTech's last funding round?

LinaTech's most recent funding round was Series B on February 27, 2022.

Who are the main investors in LinaTech?

Key investors in LinaTech include 健壹资本, CITIC Industrial Investment.

Will LinaTech IPO soon?

No public IPO plans have been announced for LinaTech.

How can I track LinaTech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor LinaTech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSuzhou
Employee Range11
Year Founded2010
Last FundingFeb 27, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?